These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 23909965

  • 1. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y, Hashimoto M, Kaneda K, Honda K, Ogawa Y, Yuuki S, Ikeda M.
    Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H.
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [Abstract] [Full Text] [Related]

  • 3. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 4. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec 31; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 31; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 6. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
    Manabe Y, Ino T, Yamanaka K, Kosaka K.
    Psychogeriatrics; 2016 May 31; 16(3):202-8. PubMed ID: 26179411
    [Abstract] [Full Text] [Related]

  • 7. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
    Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R.
    Dement Geriatr Cogn Disord; 2006 May 31; 21(5-6):353-63. PubMed ID: 16508298
    [Abstract] [Full Text] [Related]

  • 8. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.
    Psychogeriatrics; 2016 Mar 31; 16(2):85-92. PubMed ID: 25918972
    [Abstract] [Full Text] [Related]

  • 9. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.
    Neurology; 2009 May 05; 72(18):1555-61. PubMed ID: 19176895
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A, Gauthier S, Perdomo C.
    Int J Geriatr Psychiatry; 2007 Aug 05; 22(8):806-12. PubMed ID: 17199235
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.
    Clin Ther; 2010 Jul 05; 32(7):1234-51. PubMed ID: 20678673
    [Abstract] [Full Text] [Related]

  • 12. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan.
    Arai H, Sumitomo K, Sakata Y, Daidoji K, Takase T, Toyoda T.
    Psychogeriatrics; 2016 Mar 05; 16(2):107-15. PubMed ID: 26114729
    [Abstract] [Full Text] [Related]

  • 13. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
    Ishikawa K, Motoi Y, Mizuno Y, Kubo S, Hattori N.
    Psychogeriatrics; 2014 Jun 05; 14(2):93-100. PubMed ID: 24661498
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    Homma A, Atarashi H, Kubota N, Nakai K, Takase T.
    J Alzheimers Dis; 2016 Mar 11; 52(1):345-57. PubMed ID: 26967222
    [Abstract] [Full Text] [Related]

  • 15. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.
    Int J Geriatr Psychiatry; 2004 Jan 11; 19(1):58-67. PubMed ID: 14716700
    [Abstract] [Full Text] [Related]

  • 16. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.
    J Neurol Sci; 2012 Nov 15; 322(1-2):96-101. PubMed ID: 22959283
    [Abstract] [Full Text] [Related]

  • 17. Two galantamine titration regimens in patients switched from donepezil.
    Engedal K, Davis B, Richarz U, Han J, Schäuble B, Andreasen N.
    Acta Neurol Scand; 2012 Jul 15; 126(1):37-44. PubMed ID: 21992111
    [Abstract] [Full Text] [Related]

  • 18. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S, Kameda A, Inagaki T, Horiguchi J.
    Psychiatry Clin Neurosci; 2004 Dec 15; 58(6):660-5. PubMed ID: 15601392
    [Abstract] [Full Text] [Related]

  • 19. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
    Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H, LEADe investigators.
    Alzheimers Dement; 2008 Mar 15; 4(2):145-53. PubMed ID: 18631958
    [Abstract] [Full Text] [Related]

  • 20. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2008 Mar 15; 25(5):399-407. PubMed ID: 18391486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.